© 2001Pro Health, Inc.,
Immune Support.com
August 17, 2001
Scientists Discover Key to Melatonin Production
and Regulation of Circadian Rhythms
________________________________________________________________________________________________________________
________________________________________________________________________________________________________________
N
euroscientists at Jefferson Medical College have
clarified how the human eye uses light to
regulate melatonin production, and in turn, the
body's biological clock. Their observations are
published in the August 15 issue of the
Journal of
Neuroscience.
The scientists discovered what appears to be a fifth
human "photoreceptor," which is the main one to
regulate the biological - and non-visual - effects of light
on the body. They have identified a novel photopigment
in the human eye responsible for reacting to light and
controlling the production of melatonin, which plays an
important role in the body's circadian rhythms. They
also discovered that wavelengths of light in the blue
region of the visible spectrum are the most effective in
controlling melatonin production.
"We have strong evidence for a novel, fifth
photoreceptor and it appears to be independent of the
classic photoreceptor for vision. It influences the
biological effects of light. It regulates circadian rhythms
and hormones in the body. We've also shown the
fingerprint of wavelength sensitivity for the regulation
of the hormone melatonin," said
George Brainard, Ph.D., professor of neurology at
Jefferson Medical College of Thomas Jefferson
University in Philadelphia.
"This discovery will have an immediate impact on
the therapeutic use of light for treating winter depression
and circadian disorders," he adds. "Some makers of light
therapy equipment are developing prototypes with
enhanced blue light stimuli.
Four cells in the human retina capture light and form
the visual system. One type, rod cells, regulates night
vision. The other three types, called cone cells, control
color vision. It's known that exposure to light at night
can disrupt the body's production of melatonin, which is
produced by the pineal gland in the brain and plays a
vital role in resetting the body's daily biological clock.
Earlier this year, Dr. Brainard and his group showed
that the combined three-cone system didn't control the
biological effects of light, at least not for melatonin
regulation. But subsequent work led to the surprising
discovery that a novel receptor was responsible for the
effect.
"We didn't anticipate this at all," he says.
In the study, they looked at the effects of different
wavelengths of light on 72 healthy volunteers, exposing
them to nine different wavelengths, from indigo to
orange. Subjects were brought into the laboratory at
midnight, when melatonin is highest. The subjects'
pupils were dilated and then they were blindfolded for
two hours. Blood samples were drawn.
Next, each person was exposed to a specific dose of
photons of one light for 90 minutes, and then another
blood sample was drawn. Wavelengths of blue light had
the highest potency in causing changes in melatonin
levels, he explains.
In theory, he says, "If a clinician wants to use light
therapeutically, the blue wavelengths may be more
effective. If you wanted built-in illumination that would
enhance circadian regulation, you might want this
wavelength region emphasized. In contrast, if you
wanted something that doesn't produce biological
stimulation, you might steer the light more toward the
red wavelengths." But controlled clinical trials will be
needed, he adds. Next, Dr. Brainard's team would like to
study the next step in how light regulates not just
melatonin, but all of the body's circadian rhythms,
including body temperature, cortisol and performance
rhythms. The National Institute of Neurological
Disorders and Stroke, the National Space Biomedical
Research Institute and NASA funded the research.